Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial.
Hum Vaccin Immunother
; 19(2): 2263228, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-37843437
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rotavirus Infections
/
Rotavirus
/
Rotavirus Vaccines
Limits:
Humans
/
Infant
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2023
Document type:
Article
Country of publication: